Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Fibroids Article
This is a selection made from among articles on Drug Treatment Fibroids. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Alcohol and Drug Rehab: Substance Abuse and Mental Health Issues
By Jonathan Huttner
According to the National Institute of Mental Health, depression is the most common diagnosis among adults in the United States today. It is estimated that one out of three depressed people suffer from some form of addiction or substance abuse problem. In addition to the above, there appears to be a common tendency among those suffering from depression to abuse drugs or alcohol as a means of coping with their symptoms. Many of these people end up with an addiction to those substances.
Dual diagnosis can create a very complex situation for both the professional, as well as, the individual. One of the obstacles they face is while the person may feel depressed, there are many drugs, including alcohol that create symptoms similar in nature to depression. The "million dollar" question is, which came first, the depressive disorder or the addiction/alcoholism causing it?
Although there appears to be a clear link between depression and addiction or drug/alcohol use, it is not clear that one necessarily precedes the other. Many times though, the depressive disorder appears first and the person begins to use drugs or alcohol as a means to better cope with the symptoms. This type of self-medication generally leads to addiction or alcoholism with the person in need of drug rehab or alcoholism treatment. Regardless of which issue develops first, they must be treated co-currently in rehab for the person to fully recover.
The most important thing is to work with a physician who fully understands drug addiction, alcoholism and is associated with an accredited addiction treatment center.
Jonathan Huttner is one of the the principals at Lakeview Health Systems, an addiction treatment, alcohol and drug rehab facility. Addiction treatment information and free live help 24/7 is being provided online at RecoveryConnection.org
Article Source: http://EzineArticles.com/?expert=Jonathan_Huttner
http://EzineArticles.com/?Alcohol-and-Drug-Rehab:-Substance-Abuse-and-Mental-Health-Issues&id=176365
Drug Treatment Fibroids Specific links
Drug Treatment Fibroids News
Repros' Proellex(R)-V Clears Important Hurdle in Uterine Fibroid Program
THE WOODLANDS, Texas -- Repros Therapeutics Inc.(R) today announced its Proellex-V, or vaginally delivered Proellex, for the treatment of uterine fibroids, has passed an important first hurdle on the road ...
Read more...Celsion Announces Resubmission With Philips Healthcare of Combined IND/IDE Application for a Phase 2 Study of ...
LAWRENCEVILLE, NJ-- - Celsion Corporation , a leading oncology drug development company, today announced a joint resubmission with Philips Healthcare of an Investigational New Drug/Investigational Device ...
Read more...Your Health: Focused ultrasound for uterine fibroids
Uterine fibroids common in women, but treatments vary
Read more...Hospital offers new ultrasound treatment
Uterine fibroids are common and, in most cases, harmless.
Read more...Celsion Corporation and Focused Ultrasound Foundation to Support Research Exploring ThermoDox(R) Combined With Focused ...
LAWRENCEVILLE, NJ and CHARLOTTESVILLE, VA-- - Celsion Corporation and the Focused Ultrasound Foundation announced today their support for preclinical studies designed to explore the use of ThermoDox®, ...
Read more...Neurocrine Biosciences Announces Urocortin 2 Phase II Study Results in Patients With Acute Decompensated Heart Failure
SAN DIEGO, May 17, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced efficacy and safety results from a Phase II trial of urocortin 2 in 53 patients with acute decompensated ...
Read more...Repros Says Proellex-V Clears Important Hurdle In Uterine Fibroid Program
Repros Says Proellex-V Clears Important Hurdle In Uterine Fibroid Program
Read more...Neurocrine Biosciences Reports First Quarter 2012 Results
SAN DIEGO, May 2, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) today announced its financial results for the quarter ended March 31, 2012. For the first quarter of 2012, the Company ...
Read more...Breast-cancer fallout includes facing up to infertility
Staff writer Andrea Torres chronicles her breast cancer experiences in Tropical Life. Read past columns at MiamiHerald.com/health.
Read more...